QualityStocksNewsBreaks Archives - Page 664 of 1557

ThursdayNov 11, 2021 1:04 pm

QualityStocksNewsBreaks – AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Issues Update on Underwritten Public Offering of American Depositary Shares

AnPac Bio (NASDAQ: ANPC) today issued a correction to its press release dated Nov. 9, 2021, regarding the pricing of its underwritten public offering of American Depositary Shares (“ADSs”). According to the update, the original release referenced the dollar size of the offering and the number of ADSs being sold to include the exercise of the over-allotment option rather than just the base offering. The expected closing date has been updated to Nov. 15, 2021, for the offering of 1,132,111 ADSs, each at a public offering price of $2.22, for approximately $2.5 million in gross proceeds to the company. In connection with…

ThursdayNov 11, 2021 12:59 pm

QualityStocksNewsBreaks – FingerMotion Inc.’s (FNGR) Q2 Results Represent ‘Transition to Greater Profitability’

FingerMotion (OTCQX: FNGR), a communications and big data technology platform builder, recently released its Q2 results. “The China-focused enterprise reported quarterly revenue of $5.39 million, which included a 25% year-over-year quarterly growth in its short and multimedia messaging (‘SMS’ and ‘MMS’) business revenue of $0.73 million,” reads a recent article. According to CEO Martin Shen, the company is seeing unabated growth with SMS texting due to its optimized prepayments of bulk inventory purchases — the subscription plan and mobile phone sales contributed to this growth. FNGR is also seeing strong demand in SMS from its corporate clientele. “Despite the positive…

ThursdayNov 11, 2021 12:45 pm

QualityStocksNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Partnerships to Facilitate TRP-8803’s Advancement

Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) recently announced a collaboration with researchers at the University of Wisconsin-Madison as part of preparations toward planned phase 2b studies. Under the partnership, Dr. Paul Hutson, PharmD, and Dr. Christopher Nicholas, Ph.D., will support clinical pharmacology studies for TRP-8803, Tryp’s proprietary drug formulation with a novel route of administration. Once completed, the studies will provide additional regulatory support for TRP-8803. The pair will also serve as investigators on a clinical pharmacology study to evaluate the safety and pharmacokinetics of TRP-8803. “This partnership is the latest in a series of collaborations with scholars, institutions and…

ThursdayNov 11, 2021 12:31 pm

QualityStocksNewsBreaks – Why Cannabis Strategic Ventures Inc. (NUGS) Is ‘One to Watch’

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, is guided by the vision to acquire and scale assets in the legal cannabis market while achieving efficiencies through economies of scale and vertical integration. “Cannabis Strategic Ventures recently expanded its portfolio by completing the transfer process for cultivation, retail, distribution and manufacturing licenses issued by the city of Los Angeles and the state of California, and it is now working toward taking operational control of each license,” reads a recent article. Its brand portfolio includes NUGS, the NUGS Farm North and MDRN Tree. NUGS provides emerging…

ThursdayNov 11, 2021 12:30 pm

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Secures Second US Patent for Innovative UST(TM) Platform, NanoGap(TM) Valve

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialized services to the worldwide life sciences and other key industries, today announced the award of its second U.S. patent for its revolutionary Ultra Shear Technology(TM) (UST(TM)) platform. Entitled “Ultrahigh Pressure Compact Valve with Throttling Capability,” the new patent brings the company’s intellectual property (“IP”) estate to a total of seven UST patents (two in the U.S.) and 30 pressure-based patents worldwide. “The conversion of a coarser emulsion into a high-quality nanoemulsion with ultra-low droplet size is made possible by intense…

ThursdayNov 11, 2021 12:07 pm

QualityStocksNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Strategic Coffee Business Acquisitions

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its acquisition of a majority equity interests in each of Eh Coffee Corp. and Portfolio Coffee Inc. from their respective shareholders for a purchase price comprised of common shares of PlantX and cash. With the acquisition, PlantX intends to sell the companies’ products via its online platform and physical locations. In addition, PlantX will exclusively use the curated beans to make coffee beverages in its state-of-the-art cafes located in XMarket Squamish, XMarket Venice Beach, XMarket Hillcrest, XMarket Tel Aviv, and the two upcoming XMarkets located in Hudson’s Bay stores (Yorkdale and…

ThursdayNov 11, 2021 11:08 am

QualityStocksNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Present at Jefferies London Healthcare Conference

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that its CEO Doug Drysdale will present at the Jefferies London Healthcare Conference. The event is slated to be held in a virtual format from Nov. 18-19, 2021. Drysdale’s presentation will be available on demand beginning at 8:00 a.m. GMT on Thursday, Nov. 18 through 5:00 p.m. GMT on Friday, Nov. 19. Interested parties should visit https://ibn.fm/LREaZ to register for the webcast and view the presentation. An archived webcast will be available on the company’s investor relations website. To view the full press release, visit https://ibn.fm/Xhp0W…

ThursdayNov 11, 2021 10:41 am

QualityStocksNewsBreaks – InnerScope Hearing Technologies Inc. (INND) Enters Partnership to Develop Next-Generation Hearing Aids, Hearable Products

InnerScope Hearing Technologies (OTC: INND), a leader in direct-to-consumer (“DTC”) and over-the-counter (“OTC”) hearing solutions, is partnering with Atlazo Inc. The two companies will work together to develop next-generation hearing aids and hearable products, utilizing Atlazo’s patented artificial intelligence (“AI”) hardware platform. InnerScope is confident that products powered by Atlazo’s proprietary ultra-low power System-on-Chip (“SoC”) technology will include unprecedented new features such as voice commands, continuous health monitoring, and seamless connectivity with other smart devices. The company notes that consumers will not only enjoy improved hearing in noisy environments but also find natural ways to interact with other wireless devices, including…

ThursdayNov 11, 2021 10:02 am

QualityStocksNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) First-Ever Meet Delic Experience Ranks as World’s Largest Psychedelic and Wellness Event

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has released information regarding its inaugural Meet Delic event, which was held last week in Las Vegas. The company noted that the event was sold out, with more than 2,500 people in attendance, making the psychedelic edutainment experience and business expo the largest in the world. The event agenda featured 20 hours of talks, panels and discussions presented by more than 60 thought leaders, medical professionals and wellness advocates. The company has already released dates for the next year’s Meet Delic…

WednesdayNov 10, 2021 2:31 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Eyeing Opportunities in the US, UK and EU, Generating Interest Among Latin American and Caribbean Countries

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the…

Site Search

Company Search

Category: QualityStocksNewsBreaks